IMRIS (IMRSQ) OCF Yield %: 0.00 (As of Jun. 30, 2026)


What is IMRIS OCF Yield %?

IMRIS IMRSQ OCF Yield % is 0.00 as of Jun. 30, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, IMRIS's Trailing 12-Month Cash Flow from Operations is $-10.91 Mil, and Market Cap is $0.00 Mil. Therefore, IMRIS's OCF Yield % for today is 0.00%.

The historical rank and industry rank for IMRIS's OCF Yield % or its related term are showing as below:


IMRSQ's OCF Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.79
* Ranked among companies with meaningful OCF Yield % only.

IMRIS's OCF Margin % for the quarter that ended in Dec. 2014 was %.

IMRIS OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

IMRIS OCF Yield % Related Terms

IMRIS OCF Yield % Historical Data

* Premium members only.

The historical data trend for IMRIS's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS OCF Yield % Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
OCF Yield %
Get a 7-Day Free Trial Premium Member Only -5.59 -14.76 -9.20 -55.41 -20.69

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.64 4.29 -21.46 -86.96 -14.09

IMRIS OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

IMRIS's OCF Yield % for the fiscal year that ended in Dec. 2014 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-10.91 / 52.7291856
=-20.69%

IMRIS's annualized OCF Yield % for the quarter that ended in Dec. 2014 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.857 * 4 / 52.7291856
=-14.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
IMRIS (IMRSQ) has a OCF Yield % of 0.00 as of Jun. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on IMRIS and its competitors.
Is IMRIS's OCF Yield % too high?
IMRIS's current OCF Yield % is 0.00.
How does IMRIS's OCF Yield % compare to IVOB and IGNG?
IMRIS's OCF Yield % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Yield % is 1.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on IMRIS and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMRIS's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMRIS stock overvalued right now?
IMRIS (IMRSQ) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For IMRIS (IMRSQ), the current OCF Yield % is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMRIS Business Description

Address 1230 Chaska Creek Way, Suite 100, Chaska, MN, USA, 55318
IMRIS Inc provides integrated intraoperative imaging environments that deliver real-time MRI and imaging data during surgical and interventional procedures. The Operating Suite of the company enables imaging directly within the OR, enhancing clinical decision-making. The company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables tailored for this specialized setting.